| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Medical Research Council Reproductive Biology Unit (A.E.K., R.W.K.) and Department of Obstetrics and Gynecology (H.O.D.C.), University of Edinburgh, Center for Reproductive Biology, Edinburgh, United Kingdom EH3 9ET; Department of Cell and Molecular Biology, Lund University (A.M.), S-221 00, Lund, Sweden; Department of Obstetrics and Gynecology, Karolinska Hospital (M.S.), S-171 76, Stockholm, Sweden; and University of Rochester Cancer Center (R.P.P.), Rochester, New York 14642
Address all correspondence and requests for reprints to: Dr. Anne King, Medical Research Council Reproductive Biology Unit, University of Edinburgh, Center for Reproductive Biology, Edinburgh, United Kingdom EH3 9ET. E-mail: a.e.king-1{at}sms.ed.ac.uk
CD40 is a cell surface receptor initially discovered on cells of the
hemopoietic lineage. Its primary role on immune cells is to enhance
their activation and hence their production of cytokines and
immunomodulatory molecules. Recently, CD40 has also been detected on
human fibroblasts. An emerging view of the fibroblast is that it is far
more than a structural cell, being capable of intimate interaction with
cells of the immune system. In fibroblasts from several tissues, the
engagement of CD40 with its ligand (CD40L) resulted in the secretion of
proinflammatory molecules such as interleukin-6 (IL-6) and IL-8.
Currently, there are few data about the presence of the CD40-CD40L
system in female reproductive tissues. This study investigates the
expression of CD40 by human endometrium, myometrium, and cervix both
in situ and in tissue explant-derived fibroblasts. CD40
was detected mainly in the perivascular region of endometrium,
myometrium, and cervix. Light staining for CD40 was observed in stromal
elements. Additionally, the basal epithelium of cervix expressed CD40.
Fibroblastic cells derived from all three sources express low levels of
CD40, and this is up-regulated with interferon-
treatment (500 U/mL;
72 h). When activated with interferon-
and CD40L, the
fibroblasts secreted increased amounts of IL-6, IL-8, and MCP-1. These
data suggest that the CD40-CD40L system may provide a link between the
resident structural cells of these reproductive tissues and the
infiltrating immune cells or activated platelets that may express
CD40L. The possible interaction of CD40 with CD40L may be particularly
important during events such as menstruation and cervical ripening,
where up-regulation of the proinflammatory molecules IL-6 and IL-8 is
viewed as critical for these processes. In addition, dysregulation of
this system may be a contributory factor to problems such as menstrual
dysfunction and preterm labor.
This article has been cited by other articles:
![]() |
E. Malmstrom, M. Sennstrom, A. Holmberg, H. Frielingsdorf, E. Eklund, L. Malmstrom, E. Tufvesson, M. F. Gomez, G. Westergren-Thorsson, G. Ekman-Ordeberg, et al. The importance of fibroblasts in remodelling of the human uterine cervix during pregnancy and parturition Mol. Hum. Reprod., May 1, 2007; 13(5): 333 - 341. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Koumas, T. J. Smith, S. Feldon, N. Blumberg, and R. P. Phipps Thy-1 Expression in Human Fibroblast Subsets Defines Myofibroblastic or Lipofibroblastic Phenotypes Am. J. Pathol., October 1, 2003; 163(4): 1291 - 1300. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Koumas and R. P. Phipps Differential COX localization and PG release in Thy-1+ and Thy-1- human female reproductive tract fibroblasts Am J Physiol Cell Physiol, August 1, 2002; 283(2): C599 - C608. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Koumas, A. E. King, H. O. D. Critchley, R. W. Kelly, and R. P. Phipps Fibroblast Heterogeneity : Existence of Functionally Distinct Thy 1+ and Thy 1- Human Female Reproductive Tract Fibroblasts Am. J. Pathol., September 1, 2001; 159(3): 925 - 935. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |